SCHEMBL30962799

SCHEMBL30962799

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(F)cccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIK1 P57059 2/20 0.54
▸ SIK2 Q9H0K1 2/20 0.54
▸ SIK3 Q9Y2K2 2/20 0.54
▸ TNK2 Q07912 7/20 0.53
▸ WEE1 P30291 1/20 0.51
▸ LCK P06239 2/20 0.47
▸ KDR P35968 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ TEK Q02763 1/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ SRC P12931 6/20 0.46
▸ INSR P06213 1/20 0.44
▸ MET P08581 1/20 0.44
▸ CCNT1 O60563 1/20 0.43
▸ CCNE1 P24864 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ CDK9 P50750 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27313559 1.00 SIK1 (0.54) SIK1SIK2SIK3TNK2WEE1
SCHEMBL27313416 0.95 WEE1 (0.54) SIK1SIK2SIK3TNK2WEE1
SCHEMBL27313419 0.93 SRC (0.53) SIK1SIK2SIK3TNK2WEE1
SCHEMBL30962699 0.93 SRC (0.53) SIK1SIK2SIK3TNK2WEE1
SCHEMBL30962587 0.92 SIK1 (0.48) SIK1SIK2SIK3TNK2WEE1
SCHEMBL30962688 0.92 SIK1 (0.48) SIK1SIK2SIK3TNK2WEE1
SCHEMBL30962868 0.92 WEE1 (0.51) SIK1SIK2SIK3TNK2WEE1
SCHEMBL30962956 0.92 SIK1 (0.51) SIK1SIK2SIK3TNK2WEE1
SCHEMBL30962661 0.91 LCK (0.54) SIK1SIK2SIK3TNK2WEE1
SCHEMBL27313567 0.91 LCK (0.54) SIK1SIK2SIK3TNK2WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback